The effect of lyophilised oral faecal microbial transplantation on functional outcomes in dogs with diabetes mellitus

dc.citation.volumeEarly View
dc.contributor.authorBrown R
dc.contributor.authorBarko P
dc.contributor.authorRuiz Romero JDJ
dc.contributor.authorWilliams DA
dc.contributor.authorGochenauer A
dc.contributor.authorNguyen-Edquilang J
dc.contributor.authorSuchodolski JS
dc.contributor.authorPilla R
dc.contributor.authorGanz H
dc.contributor.authorLopez-Villalobos N
dc.contributor.authorGal A
dc.date.accessioned2025-05-01T02:28:31Z
dc.date.available2025-05-01T02:28:31Z
dc.date.issued2025-04-15
dc.description.abstractObjectives: We aimed to determine if oral faecal microbiota transplantation improves indices of glycaemic control, changes the faecal dysbiosis indices, alters faecal short-chain fatty acid and bile acid profiles and increases serum glucagon-like-peptide 1 concentrations in diabetic dogs. Materials and Methods: In this prospective randomised, placebo-controlled, double-blinded pilot study, we recruited nine diabetic dogs (five faecal microbiota transplantation and four placebo) and nine healthy controls. Results: Compared to healthy dogs, diabetic dogs had altered faecal short-chain fatty acid and bile acid profiles. In the first 30 days, the faecal microbiota transplantation group had a more rapid decline in interstitial glucose; however, the mean interstitial glucose of the faecal microbiota transplantation recipients did not differ from the placebo recipients at the end of the study. Compared with placebo, faecal microbiota transplantation recipients had a decreased 24-hour water intake at day 60 and increased faecal abundance of Faecalibacterium. Clinical Significance: This study provides a proof of concept for faecal microbiota transplantation in canine diabetes, and its data could inform the design of future large-scale studies. Further investigation is required to determine whether faecal microbiota transplantation would have any role as an adjunctive therapy in canine diabetes and to elucidate the mechanisms by which faecal microbiota transplantation may provide a beneficial clinical effect in canine diabetes.
dc.description.confidentialfalse
dc.format.pagination1-15
dc.identifier.citationBrown R, Barko P, Ruiz Romero JDJ, Williams DA, Gochenauer A, Nguyen-Edquilang J, Suchodolski JS, Pilla R, Ganz H, Lopez-Villalobos N, Gal A. (2025). The effect of lyophilised oral faecal microbial transplantation on functional outcomes in dogs with diabetes mellitus. Journal of Small Animal Practice. Early View. (pp. 1-15).
dc.identifier.doi10.1111/jsap.13865
dc.identifier.eissn1748-5827
dc.identifier.elements-typejournal-article
dc.identifier.issn0022-4510
dc.identifier.urihttps://mro.massey.ac.nz/handle/10179/72833
dc.languageEnglish
dc.publisherJohn Wiley and Sons Ltd on behalf of British Small Animal Veterinary Association
dc.publisher.urihttps://onlinelibrary.wiley.com/doi/10.1111/jsap.13865
dc.relation.isPartOfJournal of Small Animal Practice
dc.rights(c) 2025 The Author/s
dc.rightsCC BY 4.0
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleThe effect of lyophilised oral faecal microbial transplantation on functional outcomes in dogs with diabetes mellitus
dc.typeJournal article
pubs.elements-id500470
pubs.organisational-groupOther
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
500470 PDF.pdf
Size:
1.37 MB
Format:
Adobe Portable Document Format
Description:
Published version.pdf
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
9.22 KB
Format:
Plain Text
Description:
Collections